• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO CORPORATION, ASHITAKA CAPIOX HEMOCONCENTRATOR; DIALYZER Back to Search Results
Catalog Number CX-BPU27001
Device Problem Complete Blockage (1094)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 03/17/2016
Event Type  malfunction  
Manufacturer Narrative
The actual device was returned to the manufacturing facility for evaluation.Visual inspection found no obvious anomalies in the appearance.The actual sample was fixed with glutarldehyde solution and the housings were removed for further inspection.It was found that clots had formed on the blood inlet and outlet sides of the device.A larger amount of clots were noted on the blood outlet side.The fiber was sliced in the longitudinal direction and its inside was inspected under electron microscope.It was found to have been clogged with the erythrocyte component.A comparative pressure drop test was conducted.The actual sample and a factory retained sample of the involved lot number were circulated with saline solution while the pressure drop was determined.The actual sample was found to have a higher pressure drop, indicating a clog in the actual sample.A factory retained sample was circulated with bovine blood, while ultrafiltrating performance and the pressure drop were determined.They were confirmed to meet manufacturing specifications.A review of the device history record of the involved product code/lot # combination was conducted with no relevant findings.A search of the complaint file found no report of this nature with the involved product/lot# combination.There is no evidence that this event was related to a device defect or malfunction.Although the exact cause cannot be definitively determined based on the available information, it is likely that the dehydrating performance of the actual sample was deteriorated due to the fibers being clogged.The device labeling does address the potential for such an occurrence in the instruction for use (ifu) with the statement such as the following: "the capiox hemoconentrator is designed to operate at flow rates within the range of 100 to 500ml/min during ultrafiltration.Do not use blood flow rates outside this range.Less than 100 ml/min blood flow may cause blood coagulation in the device." "stop using the hemoconcentrator if blood leakage, clotting or any other problem is observed.Replace it with a new one." and "do not stop blood flow during extracorporeal circulation as it may cause clotting in the system.A blood flow of at least 50ml/min is recommended even if ultrafiltration is stopped by clamping the filtrate line." (b)(4).All available information has been placed on file in quality assurance at the manufacturing facility for appropriate tracking, trending and follow-up.
 
Event Description
The user facility reported a clog in the capiox device.Follow up communication with the user facility confirmed the following information: two hours after the extracorporeal circulation started, during suspension of the circulation, the customer noticed that the dehydrating performance of the actual sample became deteriorated; blood would not flow into the actual sample; the actual sample was being perfused by only the pressure generated by the centrifugal pump; the act at that moment was higher than 1000 seconds; the amount of blood loss was unknown; and the patient was not harmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CAPIOX HEMOCONCENTRATOR
Type of Device
DIALYZER
Manufacturer (Section D)
TERUMO CORPORATION, ASHITAKA
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA  418
Manufacturer (Section G)
TERUMO CORPORATION, ASHITAKA
reg. no. 9681834
150 maimaigi-cho
fujinomiya city, shizuoka 418
JA   418
Manufacturer Contact
jennifer suh
reg. no. 2243441
2101 cottontail ln.
somerset, NJ 08873
8002837866
MDR Report Key5572973
MDR Text Key42497251
Report Number9681834-2016-00079
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K973516
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Health Professional
Type of Report Initial
Report Date 04/13/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2017
Device Catalogue NumberCX-BPU27001
Device Lot Number151215
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/22/2016
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/17/2016
Initial Date FDA Received04/13/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured12/15/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Age70 YR
Patient Weight56
-
-